staphylococcus aureus endocarditis
Showing 1 - 3 of 3
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis Trial in Philadelphia (Oritavancin Injection)
Withdrawn
- Staphylococcus Aureus Bacteremia
- Staphylococcus Aureus Endocarditis
- Oritavancin Injection
-
Philadelphia, PennsylvaniaClinical Trials Unit. University of Pennsylvania
Mar 28, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis Trial in Worldwide (CF-301, Placebo)
Completed
- Staphylococcus Aureus Bacteremia
- Staphylococcus Aureus Endocarditis
- CF-301
- Placebo
-
Birmingham, Alabama
- +77 more
Sep 10, 2021